Egalet Corporation

Egalet Corporation is a fully integrated specialty pharmaceutical company based in Wayne, Pennsylvania, with 15 employees. The company focuses on developing, manufacturing, and commercializing innovative treatments for pain and other conditions. Egalet's annual revenue is $30 million. Egalet offers three approved products: ARYMO™ ER (morphine sulfate) extended-release tablets, OXAYDO® (oxycodone HCI, USP) tablets, and SPRIX® (ketorolac tromethamine) Nasal Spray. These medications are used to manage pain and are available for oral use only. Utilizing its proprietary Guardian™ Technology, Egalet is developing a pipeline of clinical-stage product candidates, including Egalet-002, an abuse-deterrent, extended-release, oral oxycodone formulation. Guardian Technology allows for the development of combination products containing multiple active pharmaceutical ingredients with varying release profiles. Egalet's Guardian Technology is a key differentiator, enabling the development of innovative and abuse-deterrent medications. This technology can be applied to various pharmaceutical products, expanding Egalet's potential for future drug development. For more information on Egalet and its products, please visit egalet.com.